Education  ·  Anti-Aging & Longevity

Not Everything in Your "Peptide Stack" Is a Peptide

MK-677, NAD+ and Klotho show up on peptide lists everywhere. None of them are peptides. Here's why the label matters more than you'd think.

By Angela  ·  October 1, 2026 ~4 min read  ·  Educational only  ·  Not medical advice

Scroll any "best longevity peptides" list and you'll find compounds that aren't peptides at all. That's not just nitpicking. What a molecule is shapes how it's absorbed, how it's regulated and how much the research on it can tell you.

What makes something a peptide?

A peptide is a short chain of amino acids, usually 2 to about 50. Longer chains fold into proteins. Molecules built from other chemistry are small molecules, coenzymes or biologics. Those categories behave differently in the body.

Four compounds that often get mislabeled

Compound Often Called What It Actually Is Why It Matters
MK-677 (ibutamoren) "GH peptide" Small-molecule ghrelin-receptor agonist Taken orally; acts like a secretagogue but has none of a peptide's structure
NAD+ "Longevity peptide" Coenzyme found in every cell Research is about NAD+ levels and precursors, not peptide signaling
Klotho "Anti-aging peptide" Large protein (roughly 1,000 amino acids) Human administration hasn't been tested; key data is in mice and one monkey study
Epitalon "Pineal peptide" A true peptide: 4 amino acids Correctly labeled, but most of its research comes from one lab group

Why the label matters

Absorption. Most peptides break down in the gut, which is why approved peptide drugs are usually injected. A small molecule like MK-677 can work orally. Calling it a peptide hides a real difference.

Regulation. US compounding rules, FDA review lists and import rules treat peptides, small molecules and biologics differently. A wrong label can mean wrong assumptions about legal status.

Evidence. A large protein like Klotho raises different questions, including manufacturing, immune response and delivery, than a 4-amino-acid peptide does. A 2023 Nature Aging study found a single low dose improved cognition in aged rhesus monkeys (Castner et al., 2023). That's promising, and it's also not a human trial.

When someone calls MK-677 a peptide, they're not just being imprecise. They're implying it shares characteristics it doesn't have: injectable-only delivery, peptide-class regulation, peptide-specific research frameworks. That matters when you're trying to evaluate what the science actually supports.

Peptexa editorial note

How Peptexa handles this

Every profile in the Peptexa guides lists the compound's true molecular class. When we found mislabeled compounds during research, including a monoclonal antibody that often appears on "peptide" lists, we corrected them and said so. Accurate labels are the first step to honest evidence.

Every compound's true class and FDA status

Molecular class, mechanism, evidence level and regulatory status for every compound in the anti-aging and longevity category. One reference, no mislabeling.

Get the Anti-Aging & Longevity Guide →

Questions I get asked

No. MK-677 (ibutamoren) is a small-molecule ghrelin-receptor agonist. It mimics the action of the peptide ghrelin but has none of a peptide's amino-acid structure. That is why it can be taken orally, unlike most peptides.
No. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It is not made of amino acids. Research on NAD+ focuses on cellular metabolism and its precursors (NMN, NR), not peptide signaling.
No. Klotho is a large protein of roughly 1,000 amino acids. Proteins and peptides are both made of amino acids, but their size, folding and behavior are fundamentally different. Human administration of Klotho has not been tested in clinical trials.
The molecular class determines how a compound is absorbed, how it is regulated and what kind of evidence applies to it. Calling a small molecule or a large protein a "peptide" can lead to wrong assumptions about oral bioavailability, legal status and the relevance of existing research.

Sources: Castner et al., "A single dose of agent reduces age-related cognitive decline in nonhuman primates," Nature Aging 2023 · PubChem: MK-677, NAD+ · DrugBank: Ibutamoren